首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1818138

分子檢測法市場報告：2031 年趨勢、預測與競爭分析

Molecular Method Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年09月19日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

全球分子檢測法市場的未來在儀器、試劑和耗材以及服務市場中充滿機會。預計2025年至2031年間，全球分子檢測法市場的複合年成長率將達到6.1%。該市場的主要驅動力是個人化醫療需求的不斷成長以及基因組學和生物技術研究的不斷深入。

Lucintel 預測，在預測期內，聚合酵素鏈鎖反應(PCR) 將在類型方面經歷最高的成長。
按應用來看，試劑和耗材預計將達到最高成長。
按地區分類，預計亞太地區將在預測期內實現最高成長。

分子檢測法市場的新趨勢

隨著技術進步和各行各業應用的不斷拓展，分子檢測法市場正在快速發展。多項發展正在重塑市場格局，提升診斷能力，並拓展分子檢測法的應用範圍。

人工智慧 (AI) 與分子診斷的整合：AI 正在透過提高數據分析和解讀的準確性來革新分子診斷。當與 PCR 和 NGS 等分子方法結合使用時，AI 演算法可以識別基因數據中的模式，從而幫助更有效地診斷癌症和遺傳性疾病等疾病。 AI 驅動的解決方案也被用於提高檢測速度並減少人為錯誤，使醫療保健提供者能夠做出更及時、更準確的決策。隨著 AI 技術的不斷發展，它很可能在分子診斷的革新中發揮關鍵作用。
新一代定序 (NGS) 的應用不斷擴展：NGS 技術正從基因研究擴展到臨床診斷，尤其是在腫瘤學、遺傳學和罕見疾病領域。 NGS 能夠實現更全面、更詳細的基因分析，從而實現精準醫療。 NGS 平台日益經濟實惠且易於獲取，這促進了其在臨床環境中的應用，有助於更早發現疾病並制定個人化治療方案。隨著基因數據量的不斷成長，NGS 正成為分子診斷和治療方案製定的重要工具。
照護現場分子診斷：隨著快速現場偵測需求的增加，尤其是在新冠疫情期間，即時分子診斷的需求日益成長。這些可攜式設備在農村和照護現場欠缺地區尤其有用，因為它們無需實驗室即可提供即時檢測和結果。即時分子診斷擴大用於感染疾病檢測、基因檢測和慢性病監測。分子診斷工具的小型化趨勢使檢測更加便捷且高效，從而推動了該領域的進一步成長。
CRISPR技術在分子診斷領域的進展：CRISPR基因編輯技術正在徹底改變分子診斷，使其能夠更準確、更有效率地檢測特定基因序列。研發人員正在開發基於CRISPR的診斷工具，以快速且準確地檢測病原體和基因突變。這些進展有望改善早期疾病檢測，並為個人化醫療提供潛在的解決方案。將CRISPR整合到分子診斷中是一個重要的趨勢，它將帶來更快、更便宜的診斷工具，惠及醫療保健和農業。
環境監測中的分子方法：分子方法在環境監測中的應用正在不斷擴展，其應用範圍從檢測水中的病原體到識別土壤中的污染物。 PCR 和 NGS 正被用於檢測飲用水中的微生物污染、評估生物多樣性以及監測入侵物種的傳播。這些方法有助於提高環境安全性和永續性，尤其是在氣候變遷和環境惡化日益加劇的背景下。隨著各國政府和組織更加重視更有效的環境監測和管理，分子方法在環境科學中的應用預計將會成長。

這些新興趨勢正在重塑分子檢測法市場，推動創新，提高可及性，並擴大應用範圍。人工智慧的整合、NGS的擴展、照護現場診斷、CRISPR技術的進步以及環境監測是將繼續塑造市場的關鍵趨勢。這些技術的進步將在醫療保健、農業和環境保護領域創造新的機遇，從而改變全球各行各業。

分子檢測法市場的最新趨勢

隨著技術的進步以及診斷和研究應用的不斷擴大，一些關鍵的發展正在影響分子檢測法市場。

快速PCR檢測平台的開發：PCR技術的最新發展促進了更快、更準確的檢測平台的開發。這些平台可以提供即時結果，這對於感染疾病診斷至關重要。 COVID-19疫情大大加速了快速PCR檢測的普及，其應用範圍目前正擴展到其他感染疾病和基因檢測。
基於 CRISPR 的診斷工具的進展：基於 CRISPR 的分子診斷工具的開發代表了市場的一個重要里程碑。這些工具能夠快速且準確地檢測基因突變和病原體。 CRISPR 診斷可在數小時內完成，非常適合照護現場，並縮短醫療保健領域的診斷週轉時間。
NGS 在臨床診斷中的應用日益廣泛：次世代定序儀(NGS) 的應用範圍正在從研究擴展到臨床診斷，尤其是在腫瘤學和罕見遺傳疾病領域。 NGS 提供全面的基因洞察，從而製定更個人化的治療方案。隨著 NGS 成本的持續下降，它有望成為臨床實踐中的標準工具，提高診斷準確性和治療效果。
永續農業的分子方法：分子方法正擴大被用於應對農業挑戰，例如疾病檢測、害蟲管理和作物基因改造。用於檢測植物病原體的分子診斷工具的開發提高了糧食安全。分子方法也被用於開發具有更強抗病蟲害能力的基因改造作物，為永續農業做出貢獻。
照護現場診斷的進展：照護現場(POC) 分子診斷設備的開發取得了重大進展，尤其是在感染疾病領域。這些可攜式、易於使用的設備可實現現場檢測，無需實驗室。即時診斷的發展使分子檢測在農村和資源匱乏地區更加普及，從而改善了全球的醫療保健成果。

這些關鍵發展正在透過提高診斷的速度、準確性和可及性來塑造分子檢測市場。 PCR、CRISPR、NGS 和 POC 診斷領域的創新正在改變醫療保健和農業，使分子檢測更加高效，並得到更廣泛的應用。

The future of the global molecular method market looks promising with opportunities in the instrument, reagents & consumables, and services markets. The global molecular method market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the rising demand for personalized medicine and increased research in genomics and biotechnology.

Lucintel forecasts that, within the type category, polymerase chain reaction (PCR) is expected to witness the highest growth over the forecast period.
Within the application category, reagents & consumables are expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Molecular Method Market

The molecular method market is evolving rapidly due to technological advancements and increasing applications in various industries. Several trends are reshaping the landscape, enhancing diagnostic capabilities, and expanding the scope of molecular methods.

Integration of Artificial Intelligence (AI) in Molecular Diagnostics: AI is transforming molecular diagnostics by improving the accuracy of data analysis and interpretation. In combination with molecular techniques like PCR and NGS, AI algorithms can identify patterns in genetic data, which aids in diagnosing diseases such as cancer and genetic disorders more effectively. AI-driven solutions are also being used to improve the speed of testing and reduce human error, enabling healthcare providers to make more timely and accurate decisions. As AI technologies continue to evolve, they will play a significant role in revolutionizing molecular diagnostics.
Expansion of Next-Generation Sequencing (NGS) Applications: NGS technologies are expanding beyond genetic research into clinical diagnostics, particularly in oncology, genetics, and rare diseases. NGS allows for more comprehensive and detailed genetic analysis, which enables precision medicine. The growing affordability and accessibility of NGS platforms are driving their use in clinical settings, facilitating early disease detection and personalized treatment plans. With the increasing volume of genetic data, NGS is becoming a key tool in molecular diagnostics and therapeutic decision-making.
Point-of-Care Molecular Diagnostics: The demand for point-of-care (POC) molecular diagnostics has been rising, especially in response to the need for rapid, on-site testing during the COVID-19 pandemic. These portable devices enable immediate testing and results without requiring a laboratory setting, which is particularly valuable in rural or underserved areas. POC molecular diagnostics are being increasingly used in infectious disease detection, genetic testing, and monitoring of chronic conditions. The trend toward miniaturization of molecular diagnostic tools is likely to drive further growth in this area, making testing more accessible and efficient.
Advancements in CRISPR Technology for Molecular Diagnostics: CRISPR gene-editing technology is revolutionizing molecular diagnostics by enabling more precise and efficient detection of specific genetic sequences. Researchers are developing CRISPR-based diagnostic tools that can quickly and accurately detect pathogens and genetic mutations. These advancements promise to improve early disease detection and offer potential solutions for personalized medicine. The integration of CRISPR into molecular diagnostics is a significant trend that could lead to faster and more affordable diagnostic tools, benefiting both healthcare and agriculture.
Molecular Methods in Environmental Monitoring: The use of molecular methods in environmental monitoring is growing, with applications ranging from detecting pathogens in water to identifying pollutants in soil. PCR and NGS are being used to detect microbial contamination in water supplies, assess biodiversity, and monitor the spread of invasive species. These methods are improving environmental safety and sustainability, particularly as concerns about climate change and environmental degradation increase. The adoption of molecular methods in environmental sciences is expected to grow as governments and organizations focus on more effective environmental monitoring and management.

These emerging trends are reshaping the molecular methods market by driving innovation, improving accessibility, and expanding the scope of applications. AI integration, NGS expansion, point-of-care diagnostics, CRISPR advancements, and environmental monitoring are key trends that will continue to shape the market. As these technologies advance, they will unlock new opportunities for healthcare, agriculture, and environmental protection, transforming industries worldwide.

Recent Developments in the Molecular Method Market

Several key developments are influencing the molecular method market, with technological advancements and growing applications in diagnostics and research.

Development of Rapid PCR Testing Platforms: Recent advancements in PCR technology have led to the development of faster and more accurate testing platforms. These platforms can deliver results in real-time, which is crucial for infectious disease diagnostics. The COVID-19 pandemic significantly accelerated the adoption of rapid PCR tests, and their application is now expanding to other infectious diseases and genetic testing.
Advancements in CRISPR-based Diagnostic Tools: The development of CRISPR-based molecular diagnostic tools is a significant milestone in the market. These tools allow for rapid and accurate detection of genetic mutations and pathogens. CRISPR diagnostics can be done in a matter of hours, making them ideal for use in point-of-care settings and reducing diagnostic turnaround times in healthcare.
Increased Use of NGS in Clinical Diagnostics: Next-generation sequencing (NGS) is expanding beyond research into clinical diagnostics, particularly in oncology and rare genetic disorders. NGS offers comprehensive genetic insights, enabling more personalized treatment plans. As the cost of NGS continues to decrease, it is expected to become a standard tool in clinical settings, improving diagnostic accuracy and treatment efficacy.
Molecular Methods for Sustainable Agriculture: Molecular methods are increasingly being used to address challenges in agriculture, including disease detection, pest management, and genetic modification of crops. The development of molecular diagnostic tools for detecting plant pathogens is improving food security. Molecular methods are also being employed to create genetically modified crops that are more resistant to pests and diseases, contributing to sustainable agriculture.
Advancements in Point-of-Care Diagnostic Devices: There has been a significant increase in the development of point-of-care (POC) molecular diagnostic devices, especially for infectious diseases. These portable and user-friendly devices enable on-site testing, eliminating the need for laboratory facilities. The growth of POC diagnostics is making molecular testing more accessible in rural and low-resource areas, improving global healthcare outcomes.

These key developments are shaping the molecular methods market by improving diagnostic speed, accuracy, and accessibility. Innovations in PCR, CRISPR, NGS, and point-of-care diagnostics are transforming healthcare and agriculture, making molecular methods more efficient and widely adopted.

Strategic Growth Opportunities in the Molecular Method Market

The molecular method market offers numerous growth opportunities across a variety of applications. As new technologies emerge, the potential for growth in healthcare, agriculture, and environmental monitoring expands.

Cancer Diagnostics and Treatment: Molecular methods are playing a key role in cancer diagnosis and treatment, with technologies such as PCR, NGS, and CRISPR being used to identify genetic mutations and biomarkers specific to various cancers. These tools enable early detection, personalized treatment, and better monitoring of treatment efficacy. The continued development of molecular methods in oncology presents significant growth opportunities.
Infectious Disease Detection and Monitoring: The demand for molecular methods in the detection and monitoring of infectious diseases has skyrocketed, particularly in response to the COVID-19 pandemic. PCR and other molecular techniques are becoming essential tools for diagnosing diseases like tuberculosis, HIV, and Zika virus. The growing need for rapid diagnostics and surveillance tools in infectious disease control offers significant market growth potential.
Agricultural Biotechnology: Molecular methods are being increasingly used in agriculture for disease detection, pest management, and crop improvement. The development of genetically modified crops and more efficient pest control methods is driving the use of molecular diagnostics in the agricultural sector. This presents significant opportunities for growth in agricultural biotechnology, particularly in developing countries where food security is a priority.
Personalized Medicine and Genomic Research: The move toward personalized medicine, where treatments are tailored to an individual's genetic profile, is driving growth in genomic research and diagnostics. Molecular methods such as NGS and CRISPR-based technologies are enabling more accurate diagnoses and targeted therapies. This growing field presents significant growth opportunities for companies developing molecular diagnostic tools.
Environmental Monitoring and Sustainability: As concerns about climate change and environmental degradation rise, molecular methods are being increasingly used for environmental monitoring. These methods help detect pollutants, monitor biodiversity, and track the spread of invasive species. The demand for molecular tools in environmental science and sustainability is expected to grow as environmental protection becomes a higher priority worldwide.

The molecular methods market offers strategic growth opportunities in various sectors, including healthcare, agriculture, and environmental monitoring. By focusing on applications such as cancer diagnostics, infectious disease detection, and sustainable agriculture, the molecular methods market is poised for continued expansion and innovation.

Molecular Method Market Driver and Challenges

The molecular methods market is influenced by technological, economic, and regulatory factors that drive growth and pose challenges.

The factors responsible for driving the molecular method market include:

1. Technological Advancements: Advances in molecular technologies like PCR, NGS, and CRISPR are driving the market by enabling more accurate and rapid diagnostics. These innovations enhance disease detection and treatment planning, particularly in oncology, infectious diseases, and genetics.

2. Increased Demand for Early Disease Detection: As healthcare systems prioritize early detection and prevention, molecular methods are in high demand. Technologies that enable early diagnosis of conditions like cancer, genetic disorders, and infectious diseases are seeing significant growth.

3. Personalized Medicine: Personalized medicine is driving the adoption of molecular methods by offering tailored treatment plans based on genetic and molecular profiles. Technologies like NGS and CRISPR are essential for delivering personalized therapies.

4. Expanding Applications in Agriculture: Molecular methods are increasingly being used in agriculture for pathogen detection, pest management, and the development of genetically modified crops. This shift toward molecular-based agriculture is driving growth in the sector.

5. Rising Healthcare Expenditure: Global increases in healthcare spending are contributing to the adoption of advanced diagnostic technologies, including molecular methods. As healthcare providers invest in state-of-the-art diagnostic tools, the market for molecular methods expands.

Challenges in the molecular method market are:

1. High Costs of Molecular Methods: The cost of advanced molecular methods, including PCR, NGS, and CRISPR, remains a barrier to adoption in many regions. High costs can limit access to these technologies, particularly in low-income areas.

2. Regulatory Hurdles: The complex and varied regulatory requirements across countries pose challenges for the market. Different approval processes for molecular diagnostic devices and treatments can delay product launches and market entry.

3. Limited Awareness and Education: In some regions, there is limited awareness of the benefits and capabilities of molecular methods. Educating healthcare professionals and the public about the value of these technologies is crucial to driving adoption.

The molecular methods market is driven by technological advancements, increased demand for early disease detection, and the rise of personalized medicine. However, challenges such as high costs, regulatory barriers, and limited awareness need to be addressed to unlock the full potential of the market. Overcoming these challenges will support the continued growth and widespread adoption of molecular methods.

List of Molecular Method Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies molecular method companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the molecular method companies profiled in this report include-

Qiagen
3M
Veredus Laboratories
Neogen Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
BioMerieux
Archerdx
Himedia Laboratories
Eurofins Scientific

Molecular Method Market by Segment

The study includes a forecast for the global molecular method market by type, application, and region.

Molecular Method Market by Type [Value from 2019 to 2031]:

Polymerase Chain Reaction (PCR)
Immunoassay
Biosensors
Microarray
Other

Molecular Method Market by Application [Value from 2019 to 2031]:

Instrument
Reagents & Consumables
Services

Molecular Method Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Molecular Method Market

The molecular methods market has seen significant advancements in recent years due to innovations in diagnostic tools, biotechnology, and research methodologies. These techniques are pivotal in numerous sectors, including healthcare, agriculture, and environmental science. As the demand for more accurate and rapid testing grows, the molecular methods market has expanded globally. The United States, China, Germany, India, and Japan are key players in this market, each contributing unique advancements and driving innovation in their respective regions. In this overview, we will explore the recent developments within these countries.

United States: In the United States, molecular methods, particularly PCR (polymerase chain reaction) and next-generation sequencing (NGS), continue to lead to advancements in genetic testing, diagnostics, and personalized medicine. The COVID-19 pandemic significantly boosted the demand for molecular diagnostics, accelerating innovation in the development of rapid testing solutions. Furthermore, the integration of AI and machine learning in molecular diagnostics is gaining traction, enabling better data interpretation and faster diagnoses. The U.S. is also focusing on expanding research into CRISPR gene editing techniques, which will significantly impact various fields, including agriculture and healthcare.
China: China is increasingly focusing on expanding its molecular method capabilities in both healthcare and agricultural sectors. The country has made significant strides in NGS and PCR technologies, particularly for the early detection of infectious diseases and genetic conditions. The Chinese government has also invested heavily in biotechnology research, aiming to improve diagnostics and healthcare infrastructure. Additionally, China is leading efforts to develop molecular methods for agricultural applications, including the detection of plant pathogens and the development of genetically modified crops, which could further boost food security and sustainability.
Germany: Germany is at the forefront of applying molecular methods in diagnostics and research, with significant contributions to PCR and NGS technologies. The country's strong biotech industry is driving innovations in molecular diagnostics, particularly in oncology and infectious diseases. Researchers in Germany are developing cutting-edge molecular tools to detect genetic mutations and markers associated with various cancers, enabling earlier detection and more effective treatments. Germany is also focusing on expanding its research in molecular biology for agricultural uses, including the development of sustainable farming practices through molecular methods.
India: The Indian molecular methods market is rapidly evolving, driven by the need for affordable diagnostic solutions and advancements in biotechnology. PCR technology is widely used for diagnosing infectious diseases, including tuberculosis and COVID-19. However, India still faces challenges with access to high-quality molecular diagnostic tools in rural areas. Efforts are being made to develop more cost-effective molecular testing platforms and expand access across the country. India is also focusing on the research and development of molecular methods for improving crop yield and pest management in agriculture.
Japan: Japan remains a leader in molecular research, particularly in healthcare and agriculture. The country is heavily investing in advancements in molecular diagnostic tools for early detection of diseases like cancer, Alzheimer's, and cardiovascular diseases. Japan's molecular biology research is advancing the use of gene-editing tools such as CRISPR-Cas9. Additionally, the country is making strides in molecular methods for enhancing food security by developing more robust crops and improving food safety through pathogen detection technologies. Japan's continued investments in biotechnology ensure its leadership in innovation of molecular methods.

Features of the Global Molecular Method Market

Market Size Estimates: Molecular method market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Molecular method market size by type, application, and region in terms of value ($B).
Regional Analysis: Molecular method market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the molecular method market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the molecular method market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the molecular method market by type (polymerase chain reaction (PCR), immunoassay, biosensors, microarray, and other), application (instrument, reagents & consumables, and services), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Molecular Method Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Polymerase Chain Reaction (PCR): Trends and Forecast (2019-2031)
4.4 Immunoassay: Trends and Forecast (2019-2031)
4.5 Biosensors: Trends and Forecast (2019-2031)
4.6 Microarray: Trends and Forecast (2019-2031)
4.7 Other: Trends and Forecast (2019-2031)

5. Global Molecular Method Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Instrument: Trends and Forecast (2019-2031)
5.4 Reagents & Consumables: Trends and Forecast (2019-2031)
5.5 Services: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Molecular Method Market by Region

7. North American Molecular Method Market

7.1 Overview
7.2 North American Molecular Method Market by Type
7.3 North American Molecular Method Market by Application
7.4 United States Molecular Method Market
7.5 Mexican Molecular Method Market
7.6 Canadian Molecular Method Market

8. European Molecular Method Market

8.1 Overview
8.2 European Molecular Method Market by Type
8.3 European Molecular Method Market by Application
8.4 German Molecular Method Market
8.5 French Molecular Method Market
8.6 Spanish Molecular Method Market
8.7 Italian Molecular Method Market
8.8 United Kingdom Molecular Method Market

9. APAC Molecular Method Market

9.1 Overview
9.2 APAC Molecular Method Market by Type
9.3 APAC Molecular Method Market by Application
9.4 Japanese Molecular Method Market
9.5 Indian Molecular Method Market
9.6 Chinese Molecular Method Market
9.7 South Korean Molecular Method Market
9.8 Indonesian Molecular Method Market

10. ROW Molecular Method Market

10.1 Overview
10.2 ROW Molecular Method Market by Type
10.3 ROW Molecular Method Market by Application
10.4 Middle Eastern Molecular Method Market
10.5 South American Molecular Method Market
10.6 African Molecular Method Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Molecular Method Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Qiagen
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 3M
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Veredus Laboratories
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Neogen Corporation
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Thermo Fisher Scientific
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Bio-Rad Laboratories
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 BioMerieux
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.9 Archerdx
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.10 Himedia Laboratories
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.11 Eurofins Scientific
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

簡介目錄圖表

List of Figures

Figure 1.1: Trends and Forecast for the Global Molecular Method Market
Figure 2.1: Usage of Molecular Method Market
Figure 2.2: Classification of the Global Molecular Method Market
Figure 2.3: Supply Chain of the Global Molecular Method Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Molecular Method Market
Figure 4.1: Global Molecular Method Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Molecular Method Market ($B) by Type
Figure 4.3: Forecast for the Global Molecular Method Market ($B) by Type
Figure 4.4: Trends and Forecast for Polymerase Chain Reaction (PCR) in the Global Molecular Method Market (2019-2031)
Figure 4.5: Trends and Forecast for Immunoassay in the Global Molecular Method Market (2019-2031)
Figure 4.6: Trends and Forecast for Biosensors in the Global Molecular Method Market (2019-2031)
Figure 4.7: Trends and Forecast for Microarray in the Global Molecular Method Market (2019-2031)
Figure 4.8: Trends and Forecast for Other in the Global Molecular Method Market (2019-2031)
Figure 5.1: Global Molecular Method Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Molecular Method Market ($B) by Application
Figure 5.3: Forecast for the Global Molecular Method Market ($B) by Application
Figure 5.4: Trends and Forecast for Instrument in the Global Molecular Method Market (2019-2031)
Figure 5.5: Trends and Forecast for Reagents & Consumables in the Global Molecular Method Market (2019-2031)
Figure 5.6: Trends and Forecast for Services in the Global Molecular Method Market (2019-2031)
Figure 6.1: Trends of the Global Molecular Method Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Molecular Method Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Molecular Method Market (2019-2031)
Figure 7.2: North American Molecular Method Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Molecular Method Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Molecular Method Market ($B) by Type (2025-2031)
Figure 7.5: North American Molecular Method Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Molecular Method Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Molecular Method Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Molecular Method Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Molecular Method Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Molecular Method Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Molecular Method Market (2019-2031)
Figure 8.2: European Molecular Method Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Molecular Method Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Molecular Method Market ($B) by Type (2025-2031)
Figure 8.5: European Molecular Method Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Molecular Method Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Molecular Method Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Molecular Method Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Molecular Method Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Molecular Method Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Molecular Method Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Molecular Method Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Molecular Method Market (2019-2031)
Figure 9.2: APAC Molecular Method Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Molecular Method Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Molecular Method Market ($B) by Type (2025-2031)
Figure 9.5: APAC Molecular Method Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Molecular Method Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Molecular Method Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Molecular Method Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Molecular Method Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Molecular Method Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Molecular Method Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Molecular Method Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Molecular Method Market (2019-2031)
Figure 10.2: ROW Molecular Method Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Molecular Method Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Molecular Method Market ($B) by Type (2025-2031)
Figure 10.5: ROW Molecular Method Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Molecular Method Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Molecular Method Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Molecular Method Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Molecular Method Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Molecular Method Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Molecular Method Market
Figure 11.2: Market Share (%) of Top Players in the Global Molecular Method Market (2024)
Figure 12.1: Growth Opportunities for the Global Molecular Method Market by Type
Figure 12.2: Growth Opportunities for the Global Molecular Method Market by Application
Figure 12.3: Growth Opportunities for the Global Molecular Method Market by Region
Figure 12.4: Emerging Trends in the Global Molecular Method Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Molecular Method Market by Type and Application
Table 1.2: Attractiveness Analysis for the Molecular Method Market by Region
Table 1.3: Global Molecular Method Market Parameters and Attributes
Table 3.1: Trends of the Global Molecular Method Market (2019-2024)
Table 3.2: Forecast for the Global Molecular Method Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Molecular Method Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Molecular Method Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Molecular Method Market (2025-2031)
Table 4.4: Trends of Polymerase Chain Reaction (PCR) in the Global Molecular Method Market (2019-2024)
Table 4.5: Forecast for Polymerase Chain Reaction (PCR) in the Global Molecular Method Market (2025-2031)
Table 4.6: Trends of Immunoassay in the Global Molecular Method Market (2019-2024)
Table 4.7: Forecast for Immunoassay in the Global Molecular Method Market (2025-2031)
Table 4.8: Trends of Biosensors in the Global Molecular Method Market (2019-2024)
Table 4.9: Forecast for Biosensors in the Global Molecular Method Market (2025-2031)
Table 4.10: Trends of Microarray in the Global Molecular Method Market (2019-2024)
Table 4.11: Forecast for Microarray in the Global Molecular Method Market (2025-2031)
Table 4.12: Trends of Other in the Global Molecular Method Market (2019-2024)
Table 4.13: Forecast for Other in the Global Molecular Method Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Molecular Method Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Molecular Method Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Molecular Method Market (2025-2031)
Table 5.4: Trends of Instrument in the Global Molecular Method Market (2019-2024)
Table 5.5: Forecast for Instrument in the Global Molecular Method Market (2025-2031)
Table 5.6: Trends of Reagents & Consumables in the Global Molecular Method Market (2019-2024)
Table 5.7: Forecast for Reagents & Consumables in the Global Molecular Method Market (2025-2031)
Table 5.8: Trends of Services in the Global Molecular Method Market (2019-2024)
Table 5.9: Forecast for Services in the Global Molecular Method Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Molecular Method Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Molecular Method Market (2025-2031)
Table 7.1: Trends of the North American Molecular Method Market (2019-2024)
Table 7.2: Forecast for the North American Molecular Method Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Molecular Method Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Molecular Method Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Molecular Method Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Molecular Method Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Molecular Method Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Molecular Method Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Molecular Method Market (2019-2031)
Table 8.1: Trends of the European Molecular Method Market (2019-2024)
Table 8.2: Forecast for the European Molecular Method Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Molecular Method Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Molecular Method Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Molecular Method Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Molecular Method Market (2025-2031)
Table 8.7: Trends and Forecast for the German Molecular Method Market (2019-2031)
Table 8.8: Trends and Forecast for the French Molecular Method Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Molecular Method Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Molecular Method Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Molecular Method Market (2019-2031)
Table 9.1: Trends of the APAC Molecular Method Market (2019-2024)
Table 9.2: Forecast for the APAC Molecular Method Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Molecular Method Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Molecular Method Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Molecular Method Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Molecular Method Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Molecular Method Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Molecular Method Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Molecular Method Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Molecular Method Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Molecular Method Market (2019-2031)
Table 10.1: Trends of the ROW Molecular Method Market (2019-2024)
Table 10.2: Forecast for the ROW Molecular Method Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Molecular Method Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Molecular Method Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Molecular Method Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Molecular Method Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Molecular Method Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Molecular Method Market (2019-2031)
Table 10.9: Trends and Forecast for the African Molecular Method Market (2019-2031)
Table 11.1: Product Mapping of Molecular Method Suppliers Based on Segments
Table 11.2: Operational Integration of Molecular Method Manufacturers
Table 11.3: Rankings of Suppliers Based on Molecular Method Revenue
Table 12.1: New Product Launches by Major Molecular Method Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Molecular Method Market

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

全球分子檢測方法市場規模、佔有率、趨勢和成長分析報告（2026-2034）

分子檢測方法市場按產品類型、技術、應用和最終用戶分類－2025-2032年全球預測

FAQ

分子檢測法市場報告：2031 年趨勢、預測與競爭分析

Molecular Method Market Report: Trends, Forecast and Competitive Analysis to 2031

目錄

第1章執行摘要

第2章 市場概況

第3章：市場趨勢及預測分析

4. 全球分子檢測法市場類型

5. 全球分子檢測法市場（按應用）

第6章 區域分析

7. 北美分子檢測法市場

8. 歐洲分子檢測法市場

9. 亞太地區分子檢測法市場

10. 世界其他地區分子檢測法市場

第11章 競爭分析

第12章：機會與策略分析

第13章 價值鏈主要企業的公司簡介

第14章 附錄